Total α-synuclein levels were found to be reduced in the cerebrospinal fluid (CSF) of PD patients compared to healthy controls [5,6,7,8], while measurements in plasma/serum provided more variable results [9,10,11]. This evidence concerns the gene SNCA and Parkinson disease.